GB0819543D0 - Treatment of proteostatic disease - Google Patents

Treatment of proteostatic disease

Info

Publication number
GB0819543D0
GB0819543D0 GB0819543A GB0819543A GB0819543D0 GB 0819543 D0 GB0819543 D0 GB 0819543D0 GB 0819543 A GB0819543 A GB 0819543A GB 0819543 A GB0819543 A GB 0819543A GB 0819543 D0 GB0819543 D0 GB 0819543D0
Authority
GB
United Kingdom
Prior art keywords
treatment
proteostatic
disease
proteostatic disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0819543A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Summit Therapeutics Ltd
Original Assignee
Summit Corp PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Summit Corp PLC filed Critical Summit Corp PLC
Priority to GB0819543A priority Critical patent/GB0819543D0/en
Publication of GB0819543D0 publication Critical patent/GB0819543D0/en
Priority to US13/057,654 priority patent/US20110237538A1/en
Priority to EP09784866A priority patent/EP2323652A2/en
Priority to PCT/GB2009/001918 priority patent/WO2010015816A2/en
Ceased legal-status Critical Current

Links

GB0819543A 2008-08-06 2008-10-24 Treatment of proteostatic disease Ceased GB0819543D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB0819543A GB0819543D0 (en) 2008-10-24 2008-10-24 Treatment of proteostatic disease
US13/057,654 US20110237538A1 (en) 2008-08-06 2009-08-04 Treatment of lysosomal storage disorders and other proteostatic diseases
EP09784866A EP2323652A2 (en) 2008-08-06 2009-08-04 Treatment of lysosomal storage disorders and other proteostatic diseases
PCT/GB2009/001918 WO2010015816A2 (en) 2008-08-06 2009-08-04 Treatment of lysosomal storage disorders and other proteostatic diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0819543A GB0819543D0 (en) 2008-10-24 2008-10-24 Treatment of proteostatic disease

Publications (1)

Publication Number Publication Date
GB0819543D0 true GB0819543D0 (en) 2008-12-03

Family

ID=40133781

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0819543A Ceased GB0819543D0 (en) 2008-08-06 2008-10-24 Treatment of proteostatic disease

Country Status (1)

Country Link
GB (1) GB0819543D0 (en)

Similar Documents

Publication Publication Date Title
HUS1600057I1 (en) Methods of treatment using ammonia-scavenging drugs
IL208354A0 (en) Methods of treatment
GB2465897B (en) Respiratory disease treatment
EP2498796A4 (en) Treatment of heart disease
GB0908193D0 (en) Treatment of disease state
EP2160100A4 (en) Treatment of graft-versus-host disease
HRP20181877T1 (en) Methods of treatment using ammonia-scavenging drugs
GB0700972D0 (en) Treatment of inflammatory disease
ZA201000225B (en) Treatment of depression
GB0720976D0 (en) Treatment of inflammatory disease
EP2182976A4 (en) Treatment of autoimmune disease
GB0723100D0 (en) Treatment of HFnEF
EP2164494A4 (en) Methods of treatment
EP2507266A4 (en) TREATMENT OF IgE-MEDIATED DISEASE
GB0623740D0 (en) Treatment of disease
GB0819543D0 (en) Treatment of proteostatic disease
GB0817859D0 (en) Treatment of proteostatic disease
GB0908666D0 (en) Treatment of proteostatic disease
GB0716840D0 (en) Treatment of cardiovascular disease
GB0700969D0 (en) Methods of treatment
GB0823568D0 (en) Respiratory disease treatment
GB0814488D0 (en) Respiratory disease treatment
GB0720136D0 (en) Treatment of blood disorded
SI2330892T1 (en) Methods of treatment using ammonia-scavenging drugs
GB0901831D0 (en) Respiratory disease treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)